Literature DB >> 12620531

Dietary supplementation with fermented soybeans suppresses intimal thickening.

Yasuhiro Suzuki1, Kazunao Kondo, Hideyuki Ichise, Yoshinori Tsukamoto, Tetsumei Urano, Kazuo Umemura.   

Abstract

Although soy foods have been consumed for more than 1000 y, it is only in the past 20 y that they have made inroads into Western diets. We investigated the effect of dietary supplementation with natto extracts produced from fermented soybeans on intimal thickening of arteries after vessel endothelial denudation. Natto extracts include nattokinase, a potent fibrinolytic enzyme having four times greater fibrinolytic activity than plasmin. Intimal thickening was induced in the femoral arteries by intravenous infusion of rose bengal followed by focal irradiation with a transluminal green light. Dietary natto extract supplementation was started 3 wk before endothelial injury and continued for another 3 wk after. In ex vivo studies, euglobulin clot lysis times were measured 3 wk after the initial supplementation. Neointima formation and thickening were also initiated successfully. The intima media ratio 3 wk after endothelial injury was 0.15 +/- 0.03 in the control group. Dietary natto extract supplementation suppressed intimal thickening (0.06 +/- 0.01; P < 0.05) compared with the control group. Natto extracts shortened euglobulin clot lysis time, suggesting that their thrombolytic activities were enhanced. These findings suggest that natto extracts, because of their thrombolytic activity, suppress intimal thickening after vascular injury as a result of the inhibition of mural thrombi formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620531     DOI: 10.1016/s0899-9007(02)00853-5

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  5 in total

1.  Purification and characterization of a novel, highly potent fibrinolytic enzyme from Bacillus subtilis DC27 screened from Douchi, a traditional Chinese fermented soybean food.

Authors:  Yuanliang Hu; Dan Yu; Zhaoting Wang; Jianjun Hou; Rohit Tyagi; Yunxiang Liang; Yongmei Hu
Journal:  Sci Rep       Date:  2019-06-25       Impact factor: 4.379

2.  Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants.

Authors:  Hongjie Chen; Jiepeng Chen; Fuping Zhang; Yuanhui Li; Ronghua Wang; Qiang Zheng; Xu Zhang; Jun Zeng; Feng Xu; Yiguang Lin
Journal:  Front Cardiovasc Med       Date:  2022-08-22

3.  Escalated regeneration in sciatic nerve crush injury by the combined therapy of human amniotic fluid mesenchymal stem cells and fermented soybean extracts, Natto.

Authors:  Hung-Chuan Pan; Dar-Yu Yang; Shu-Peng Ho; Meei-Ling Sheu; Chung-Jung Chen; Shiaw-Min Hwang; Ming-Hong Chang; Fu-Chou Cheng
Journal:  J Biomed Sci       Date:  2009-08-23       Impact factor: 8.410

Review 4.  Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases.

Authors:  Hongjie Chen; Eileen M McGowan; Nina Ren; Sara Lal; Najah Nassif; Fatima Shad-Kaneez; Xianqin Qu; Yiguang Lin
Journal:  Biomark Insights       Date:  2018-07-05

5.  Antioxidation, angiotensin converting enzyme inhibition activity, nattokinase, and antihypertension of Bacillus subtilis (natto)-fermented pigeon pea.

Authors:  Bao-Hong Lee; Yi-Syuan Lai; She-Ching Wu
Journal:  J Food Drug Anal       Date:  2015-07-29       Impact factor: 6.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.